AI avatar could help cancer patients remember treatment details

NCT ID NCT07715981

Not yet recruiting Symptom relief Sponsor: Dr. Mark Mulder Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This trial tests an AI-powered avatar called ELISA that helps cancer patients learn about their treatment. Patients starting a new cancer therapy often struggle to remember complex information. The avatar provides personalized answers based on approved content. The study compares standard nurse-led education with a shortened nurse session plus ELISA, measuring how well patients recall information.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AI-generated educational videos and an interactive avatar
What this could lead to: If successful, this approach could help cancer patients better understand their treatment and reduce the burden on nurses.
What could go wrong: The AI avatar may occasionally give inaccurate information, and the trial is small and early-stage, so results may not apply broadly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.